Dr. Michael Kwesi Amponsah, MD

Dr. Amponsah practices at Cardiac Solutions in Peoria, Arizona.

Dr. Amponsah's NPI, 1518233899, was assigned on March 30, 2012. Dr. Amponsah graduated from University of Science and Technology SOM in 2008. Dr. Amponsah holds Arizona license 62556.

Dr. Amponsah's primary practice is Cardiac Solutions, at 13460 N 94th Dr Suite J1 Suite J1, Peoria, AZ 85381-4246. The practice phone is (623) 876-8816.

Dr. Amponsah's primary practice is Cardiac Solutions in Peoria, Arizona. Dr. Amponsah is also affiliated with Banner Thunderbird Medical Center. The medical group on file is Cardiac Solutions. Dmand AI also links Dr. Amponsah to 2 more hospitals, 4 medical groups and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Amponsah practices, 5 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Amponsah's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Amponsah is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Amponsah's licenses on file in 8 states: Arizona, Pennsylvania, Utah, New Jersey, Tennessee, New York, Virginia and New Mexico.

Dmand AI lists angioplasty, cardiac catheterization and leg revascularization among the conditions Dr. Amponsah treats.

CMS data shows 8,102 Medicare services from Dr. Amponsah across 47 procedure codes in 2024, for 1,343 Medicare patients. Medicare paid $495,791 for them.

CMS counts 1,343 Medicare patients who saw Dr. Amponsah in 2024. The largest group is 75 to 84, with 593 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Amponsah's median patient age at 76, with 50% women.

In 2024, Dr. Amponsah wrote 6,395 Medicare Part D claims for 1,095 patients. 86% of them were for generic drugs. CMS names the drug for 6,192 of them, across 62 drugs with 11 or more claims each, at $977,048 in total drug cost. In 2023, CMS named 4,330 claims across 53 drugs.

Dr. Amponsah accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 20 procedures of pacemaker insertion or repair by Dr. Amponsah, more than 71% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Amponsah, published from 2013 to 2021. 2013 was the busiest year, with 2. Dr. Amponsah's most frequent co-authors are Najam Wasty, MD, Jennifer En-Sian Ho, MD and James Louis Januzzi, MD.

CMS Open Payments shows 657 general payments to Dr. Amponsah from 37 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 39% of the total. AstraZeneca Pharmaceuticals LP paid the most, $17,651. It also lists 4 research payments totaling $69,500 from 2022 to 2025.

Dmand AI lists 2 awards for Dr. Amponsah, most recently Resident of the year in 2013.

Dr. Amponsah graduated from University of Science and Technology SOM in 2008.

Dr. Amponsah is in network with 19 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.